AE-3763
Names
[ CAS No. ]:
291778-77-3
[ Name ]:
AE-3763
Biological Activity
[Description]:
AE-3763 is a peptide-based human neutrophil elastase inhibitor with an IC50 of 29 nM.
[Related Catalog]:
[Target]
IC50: 29 nM (Human neutrophil elastase)[1]
[In Vitro]
AE-3763 exhibits potent in vitro inhibitory activity against human neutrophil elastase as well as extremely high solubility and stability in water[1].
[In Vivo]
Edema and leukocytes infiltration into the lung are significantly inhibited by infusion of AE-3763. AE3763 significantly improves survival rate by 24 h in a mouse model of fatal shock associated with multiple organ dysfunction. AE-3763 dose-dependently prevents hemorrhage when given intravenously by infusion (ED50: 0.42 mg/kg/h) or by bolus injection (1.2 mg/kg). With regard to the toxicity of AE-3763 in mice, the results of a preliminary study have shown no overt toxic effect even at the high dose of 300 mg/kg, iv[1].
[Animal admin]
Mice[1] D-Galactosamine shock is induced in C3H/HeN mice (6-7 w, 22-25 g). AE-3763 (10 or 100 mg/kg) is administrated intraperitoneally six times at 2 h interval. Control animals receive the vehicle (PBS) instead of AE-3763. Animal’s survival rate is observed up to 24 h after shock induction[1].
[References]
[Related Small Molecules]
DMP 777
|
GW311616
|
Sivelestat Sodium tetrahydrate
|
Alvelestat
|
BAY 678
|
BAY-85-8501
|
Lodelaben
|
ZD-0892
|
ZD8321
Chemical & Physical Properties
[ Molecular Formula ]:
C23H34F3N5O7
[ Molecular Weight ]:
549.54